[Malignant hypertension. Significance of hypovolemia in pathogenesis and therapy of malignant hypertension].
D000328:Adult; D000743:Anemia, Hemolytic / Q000150:complications; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001810:Blood Volume; D005260:Female; D006801:Humans; D006974:Hypertension, Malignant / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology*; D007676:Kidney Failure, Chronic / Q000150:complications; D010952:Plasma Substitutes / Q000627:therapeutic use; D012083:Renin / Q000097:blood; D012964:Sodium / Q000627:therapeutic use
D000959:Antihypertensive Agents; D010952:Plasma Substitutes; D012964:Sodium; D012083:Renin
Maligne Hypertonie. -edeutung der Hypovolämie in der Pathogenese und Therapie der malignen Hypertonie